Skin Biopsy Techniques
Skin biopsy is a fundamental diagnostic procedure in dermatology, primary care, and plastic surgery, used to obtain tiss... MRCS exam preparation.
Clinical board
A visual summary of the highest-yield teaching signals on this page.
Urgent signals
Safety-critical features pulled from the topic metadata.
- Shave Biopsy on suspected Melanoma (Destroys Breslow depth staging)
- Biopsy of Vascular Lesion without haemostatic preparation
- Uncontrolled Anticoagulation (INR less than 3.5)
- Active Infection at biopsy site
Exam focus
Current exam surfaces linked to this topic.
- MRCS
Linked comparisons
Differentials and adjacent topics worth opening next.
- Melanoma Staging
- Inflammatory Dermatoses
Editorial and exam context
Reviewed by MedVellum Editorial Team · MedVellum Medical Education Platform
Credentials: MBBS, MRCP, Board Certified
Skin Biopsy Techniques
1. Procedure Overview
Summary
Skin biopsy is a fundamental diagnostic procedure in dermatology, primary care, and plastic surgery, used to obtain tissue for histopathological and immunological analysis. [1,2] The four principal techniques are punch biopsy, shave biopsy, incisional biopsy, and excisional biopsy. Selection of the appropriate technique depends upon the suspected pathology, lesion depth, anatomical location, and cosmetic considerations. [3]
Correct technique selection is paramount: a shave biopsy on a suspected melanoma constitutes a serious clinical error as it prevents accurate Breslow depth measurement, which is essential for staging and determining surgical margins. [4,5] This comprehensive guide covers indications, technique selection, procedural steps, specimen handling, post-procedure care, and common pitfalls relevant to postgraduate examinations.
Key Facts
| Technique | Tissue Depth | Primary Indication | Closure | Scarring |
|---|---|---|---|---|
| Shave Biopsy | Epidermis ± superficial dermis | Raised benign lesions (SK, skin tags) | Secondary intention | Flat, hypopigmented |
| Punch Biopsy | Full-thickness (epidermis to subcutis) | Inflammatory dermatoses, bullous disease | 1-2 sutures or secondary intention | Small circular/elliptical |
| Incisional Biopsy | Partial lesion with deep tissue | Large tumours, panniculitis | Sutures | Linear |
| Excisional Biopsy | Entire lesion with margin | Suspected melanoma, complete removal | Layered closure | Elliptical |
Critical Safety Points
The Melanoma Rule: If there is ANY doubt about a pigmented lesion, excise completely with 2mm clinical margin. A shave biopsy that transects a melanoma destroys Breslow depth information essential for staging and prognosis. [4,5,6]
The SCC Rule: For suspected squamous cell carcinoma on sun-damaged skin, a deep shave (saucerization) or punch biopsy is acceptable for diagnosis, but definitive excision with appropriate margins must follow if malignancy is confirmed. [7]
The Adrenaline Myth: The historical teaching to avoid adrenaline-containing local anaesthetics in fingers, toes, ears, nose, and penis has been definitively disproven. Multiple large studies demonstrate safety with no cases of digital necrosis. [8,9,10]
The DIF Rule: For suspected autoimmune bullous disease, Direct Immunofluorescence requires perilesional skin in Michel's transport medium, NOT formalin. Formalin destroys immunoglobulins. [11,12]
Why This Matters Clinically
Skin biopsy is one of the most commonly performed procedures in medicine, with over 10 million performed annually in the United States alone. [13] A poorly chosen technique can delay diagnosis, cause cosmetic disfigurement, or destroy critical staging information for skin cancer. Every clinician performing minor surgery must master these skills and understand the clinical reasoning behind technique selection.
2. Anatomy Essentials
Skin Structure and Biopsy Depth
Understanding skin architecture is fundamental to technique selection:
| Layer | Depth | Structures | Biopsy Relevance |
|---|---|---|---|
| Epidermis | 0.1-1.5mm | Keratinocytes, melanocytes, Langerhans cells | Shave biopsy captures this |
| Papillary Dermis | 0.3-0.5mm | Superficial vascular plexus, nerve endings | Deep shave reaches here |
| Reticular Dermis | 1-4mm | Collagen bundles, deep vascular plexus, adnexae | Punch biopsy required |
| Subcutaneous Fat | Variable | Adipocytes, lobules, septa, vessels | Deep punch or incisional biopsy |
Relaxed Skin Tension Lines (RSTLs / Langer's Lines)
The key to optimal scarring in excisional biopsies:
- RSTLs run parallel to underlying muscle fibres and correspond to natural skin creases
- On the face, they follow crow's feet, nasolabial folds, and forehead creases
- Ellipse orientation: Always align the long axis of your ellipse ALONG the RSTLs
- Result: Scars fall into natural creases and become significantly less visible [14]
Danger Zones (Anatomical Hazards)
| Anatomical Site | Structure at Risk | Clinical Consequence | Prevention Strategy |
|---|---|---|---|
| Temple | Temporal branch of Facial Nerve | Brow ptosis, forehead weakness | Superficial dissection only |
| Cheek (middle third) | Parotid Duct (Stensen's) | Sialocele, fistula | Runs tragus to upper lip; stay superficial |
| Neck (posterior triangle) | Spinal Accessory Nerve | Shoulder weakness, scapular winging | Very superficial in posterior triangle |
| Hand (dorsum) | Extensor tendons | Tendon injury, functional impairment | Tendons superficial; avoid deep dissection |
| Pretibial region | Poor vascularity | Delayed healing, wound breakdown | Avoid if possible; careful technique |
Blood Supply Considerations
Regional blood supply affects healing and complication rates:
| Region | Vascularity | Healing | Special Considerations |
|---|---|---|---|
| Face/Scalp | Excellent | Rapid (5-7 days) | Bleeds well; heals well |
| Upper limb | Good | Moderate (10-14 days) | Standard technique |
| Trunk | Moderate | Moderate (10-14 days) | Tension from movement |
| Lower limb | Poor | Slow (14-21 days) | High complication rate; avoid if possible |
| Pre-tibial | Very poor | Very slow | Highest complication rate; consider alternatives |
3. Local Anaesthesia
Pharmacology
| Agent | Concentration | Onset | Duration (Plain) | Duration (+Adrenaline) | Max Dose (Plain) | Max Dose (+Adrenaline) |
|---|---|---|---|---|---|---|
| Lidocaine | 1-2% | 2-5 min | 30-60 min | 60-120 min | 3 mg/kg | 7 mg/kg |
| Bupivacaine | 0.25-0.5% | 5-15 min | 2-4 hours | 4-8 hours | 2 mg/kg | 3 mg/kg |
| Prilocaine | 1-2% | 5-10 min | 60-90 min | 2-4 hours | 6 mg/kg | 8 mg/kg |
| Topical (EMLA/LMX) | Variable | 45-60 min | 1-2 hours | N/A | Per area | N/A |
Maximum Volume Calculations
For lidocaine 1% with adrenaline (10 mg/mL):
- 70 kg adult: Maximum 7 mg/kg = 490 mg = 49 mL of 1% lidocaine with adrenaline
- 50 kg patient: Maximum 350 mg = 35 mL of 1% lidocaine with adrenaline
Practical tip: For minor skin biopsies, volumes of 1-5 mL are typical, well below toxic thresholds.
Adrenaline Safety Evidence
The traditional teaching to avoid adrenaline in digits has been definitively disproven:
| Study | Sample Size | Findings |
|---|---|---|
| Lalonde et al. 2005 [8] | 3,110 cases | Zero digital necrosis with 1:100,000 adrenaline in fingers |
| Thomson et al. 2007 [9] | 1,111 cases | No ischaemic complications in digital blocks |
| Ilicki 2015 (Systematic Review) [10] | > 10,000 cases | No reports of digital necrosis from adrenaline |
Current evidence-based practice: Adrenaline 1:100,000 or 1:200,000 is safe in all anatomical locations including digits, ears, nose, and penis when used appropriately.
Benefits of Adrenaline in Local Anaesthesia
- Vasoconstriction: Provides bloodless operative field
- Delayed absorption: Prolongs anaesthetic duration
- Reduced systemic toxicity: Lower peak plasma levels
- Reduced total anaesthetic requirement: Better tissue penetration
Injection Technique
Pain reduction strategies (evidence-based):
| Technique | Evidence Level | Mechanism |
|---|---|---|
| Slow injection (30 sec/mL) | High | Reduces tissue distension |
| Warming to body temperature | High | Reduces cold-related pain |
| Buffering with sodium bicarbonate | High | Neutralizes acidity (8.4% NaHCO3 1:10) |
| 30G needle | Moderate | Smaller puncture |
| Topical anaesthesia first | High | Numbs injection site |
4. Indications for Biopsy Technique Selection
Technique Selection Algorithm
| Clinical Scenario | Recommended Technique | Rationale |
|---|---|---|
| Inflammatory rash (psoriasis, eczema, lichen planus) | Punch (4mm) | Full dermis required for inflammatory pattern |
| Bullous disease (pemphigoid, pemphigus) | Punch (4mm) x 2 | Perilesional biopsy for DIF studies + lesional for H&E |
| Suspected melanoma (dermoscopically atypical) | Excision (2mm margin) | Full depth mandatory for Breslow staging |
| Benign raised lesion (SK, viral wart, skin tag) | Shave | Quick, minimal scarring, cosmetically acceptable |
| Nodular BCC | Deep shave or punch | Establish diagnosis; definitive surgery follows |
| Suspected SCC (crusted, keratotic) | Punch or deep shave | Confirm invasive vs. in-situ disease |
| Unknown rash | Punch (4mm from edge) | Include normal and abnormal tissue junction |
| Suspected vasculitis | Deep punch (4mm+) | Deep dermis/subcutis required for vessel wall assessment |
| Panniculitis | Incisional biopsy | Intact fat lobules required; punch inadequate |
| Large tumour for diagnosis | Incisional biopsy | Representative sample without complete excision |
| Alopecia (scarring vs. non-scarring) | Punch (4mm) from active edge | Requires follicular architecture |
Quality Markers for Skin Biopsy
| Marker | Standard | Audit Target |
|---|---|---|
| Correct technique selection | Excision for melanoma, punch for inflammatory | 100% compliance |
| Adequate specimen size | Punch ≥4mm for inflammatory dermatoses | > 95% |
| No crush artefact | Toothed forceps, gentle handling | > 95% |
| Complete clinical details | Site, duration, description, differential on form | 100% |
| Correct transport medium | H&E = Formalin; DIF = Michel's/Zeus | 100% |
| Orientation suture (if needed) | For excisions where margin matters | When indicated |
| Legible labelling | Patient ID, site, date | 100% |
5. Technique: Shave Biopsy
Definition and Mechanism
Shave biopsy removes a superficial portion of skin tangentially, including epidermis and variable amounts of dermis. The depth is controlled by blade angle and technique. [2,3]
Indications
| Appropriate | Contraindicated |
|---|---|
| Seborrhoeic keratosis | Suspected melanoma |
| Skin tags (acrochordons) | Deep dermal pathology |
| Viral warts | Subcutaneous lesions |
| Benign intradermal naevi | Lesions requiring margin assessment |
| Superficial BCC (for diagnosis) | Inflammatory dermatoses |
| Actinic keratosis | Bullous disease |
Equipment Required
- Antiseptic (chlorhexidine 0.5% in alcohol or povidone-iodine)
- Lidocaine 1-2% with adrenaline 1:100,000
- 2mL syringe, 25G (orange) needle
- No. 15 scalpel blade OR DermaBlade
- Toothed forceps (Adson or Gillies)
- Haemostatic agent (aluminium chloride 20% / ferric subsulfate)
- Specimen pot with 10% buffered formalin
- Non-adherent dressing
Procedure: Step-by-Step
Step 1: Preparation and Consent
- Explain procedure, expected outcome, scar appearance
- Document consent including: bleeding, infection, incomplete excision, scar
Step 2: Anaesthesia
- Clean site with antiseptic
- Inject local anaesthetic beneath lesion, creating a raised bleb
- Adrenaline-containing LA elevates lesion and provides haemostasis
- Wait 2-5 minutes for full effect
Step 3: Technique
- Hold blade parallel to skin surface (for superficial shave)
- Angle blade 10-15° below horizontal for deeper sampling (saucerization)
- Use gentle sawing motion to slice through base of lesion
- Support lesion with forceps if needed (avoid crushing diagnostic tissue)
- For saucerization: scoop downward to include mid-dermis
Step 4: Haemostasis
- Apply aluminium chloride 20% (Monsel's solution) with cotton-tipped applicator
- Alternative: light electrocautery or silver nitrate
- Pressure for persistent oozing
Step 5: Specimen Handling
- Place specimen in formalin immediately
- Ensure adequate formalin volume (10:1 ratio formalin:tissue)
- Label container clearly
Step 6: Dressing
- Apply non-adherent dressing (Mepitel, Adaptic, or Allevyn)
- Wound heals by secondary intention over 1-3 weeks
Saucerization (Deep Shave) Technique
For deeper sampling without ellipse:
- Angle blade 30-45° and scoop to create dish-shaped excision
- Allows sampling of mid-dermis
- Useful for: suspected BCC, thick seborrhoeic keratoses, superficial SCC
- Never for melanoma - still cannot assess true depth
Complications
| Complication | Incidence | Prevention | Management |
|---|---|---|---|
| Bleeding | 5-10% | Adrenaline LA, haemostatic agents | Pressure, cautery |
| Infection | 1-3% | Aseptic technique | Antibiotics if cellulitis |
| Hypopigmented scar | Common | Patient counselling | Cosmetic camouflage |
| Recurrence | 5-15% | Adequate depth | Re-excision |
| Inadequate specimen | 2-5% | Appropriate technique selection | Repeat biopsy |
6. Technique: Punch Biopsy
Definition and Mechanism
Punch biopsy uses a circular cutting instrument to obtain a full-thickness cylindrical core of tissue including epidermis, dermis, and variable subcutaneous tissue. This is the gold standard for inflammatory dermatoses. [1,2,15]
Indications
| Primary Indications | Rationale |
|---|---|
| Inflammatory skin disease | Full dermis shows inflammatory pattern |
| Bullous disease | Perilesional specimen for DIF |
| Connective tissue disease | Dermal collagen changes |
| Vasculitis | Deep dermal vessels required |
| Alopecia | Hair follicle architecture |
| Small pigmented lesions (if 2mm punch can excise completely) | Full-thickness assessment |
| Unknown rash | Comprehensive histological evaluation |
Punch Size Selection
| Size | Indications | Closure |
|---|---|---|
| 2mm | Eyelid, small lesions, limited tissue areas | Often no suture needed |
| 3mm | Face, standard rash | May heal without suture; 1 suture optional |
| 4mm | Gold standard for inflammatory dermatoses | 1-2 sutures required |
| 5mm | When larger sample needed | 2 sutures |
| 6mm | Panniculitis, deep tissue sampling | 2+ sutures essential |
| 8mm | Rarely used; incisional biopsy preferred | Multiple sutures |
Equipment Required
- Antiseptic solution
- Lidocaine 1-2% ± adrenaline
- Disposable sterile punch (appropriate size)
- Toothed forceps (fine-tipped)
- Iris scissors (curved)
- Suture material (non-absorbable 4-0 to 6-0 nylon or absorbable)
- Specimen pot with 10% buffered formalin (or Michel's medium for DIF)
- Needle holder
- Dressing materials
Procedure: Step-by-Step
Step 1: Site Selection
- Choose representative area of pathology
- For inflammatory disease: include junction of normal and abnormal skin
- For bullous disease: perilesional skin for DIF (uninvolved skin adjacent to blister)
- Avoid areas of secondary change (excoriation, lichenification)
Step 2: Consent and Preparation
- Explain procedure and expected scar (small circular/elliptical)
- Document consent for bleeding, infection, scarring, need for repeat biopsy
Step 3: Anaesthesia
- Clean with antiseptic
- Inject LA beneath lesion to raise bleb
- Avoid injecting into the lesion itself (distorts histology)
- Wait for full anaesthetic effect
Step 4: Skin Stretching Technique (Critical)
- Stretch skin perpendicular to RSTLs using non-dominant hand
- This converts the circular defect into an elliptical wound when tension released
- Elliptical wounds close with less tension and better cosmesis
Step 5: Punch Technique
- Apply punch perpendicular to skin surface
- Apply downward pressure with steady rotation in ONE direction
- Twist like a corkscrew (not back-and-forth - this shreds collagen)
- Continue until "give" is felt (entering subcutis)
- Withdraw punch carefully
Step 6: Specimen Removal
- Lift core gently with toothed forceps at deep edge (not crushing diagnostic tissue)
- Snip base with iris scissors at level of subcutis
- Handle specimen with minimal manipulation
Step 7: Haemostasis and Closure
- Apply pressure or cautery for haemostasis
- Close with simple interrupted suture (or allow secondary intention for ≤3mm)
- Evert wound edges for optimal healing
Step 8: Specimen Handling
- Place immediately in appropriate medium:
- Formalin for routine H&E
- Michel's medium for direct immunofluorescence
- Fresh/saline for culture or special studies
- Ensure proper labelling
Technical Pearls
One-Direction Twist: Twisting the punch back-and-forth shreds collagen fibres and creates crush artefact, potentially rendering histology uninterpretable. Always twist in one direction only.
Perilesional DIF: For bullous disease, the DIF specimen must come from perilesional UNINVOLVED skin (within 1cm of blister but not blistered). Blister fluid destroys antibodies.
The 10% Rule: Formalin volume should be at least 10x the tissue volume for adequate fixation.
Complications
| Complication | Incidence | Prevention | Management |
|---|---|---|---|
| Bleeding | 3-8% | Adrenaline, pressure | Pressure, cautery, suture |
| Infection | 1-2% | Aseptic technique | Antibiotics |
| Crush artefact | 5-10% | Toothed forceps, gentle handling | Repeat biopsy |
| Scarring (hypertrophic/keloid) | 1-5% (site dependent) | Avoid high-risk sites | Silicone, steroid injection |
| Inadequate depth | less than 5% | Appropriate punch size | Repeat with larger punch |
7. Technique: Incisional Biopsy
Definition and Indications
Incisional biopsy removes a representative portion of a larger lesion without attempting complete excision. It provides full-thickness tissue for diagnosis when complete excision is not practical or desirable initially. [3,16]
Indications
| Indication | Rationale |
|---|---|
| Large cutaneous tumours | Confirm diagnosis before definitive surgery |
| Panniculitis | Intact fat lobules required (punch often inadequate) |
| Deep soft tissue masses | Full-thickness sampling |
| Morphoea/scleroderma | Deep dermis and subcutis assessment |
| Large inflammatory lesions | Representative tissue from active edge |
| Lesions where complete excision would be morbid | Diagnostic information guides treatment planning |
Technique
Step 1: Planning
- Mark ellipse at junction of abnormal and normal tissue (lesion edge)
- For tumours: sample the most representative area (avoid necrotic centre)
- For panniculitis: include subcutaneous fat in specimen
Step 2: Ellipse Design
- Minimum 3:1 length-to-width ratio
- Align long axis with RSTLs
- Typically 1-2 cm length, 3-5 mm width
Step 3: Procedure
- Anaesthetize with field block
- Incise with No. 15 blade perpendicular to skin
- Dissect ellipse to appropriate depth (often into subcutis)
- Undermine if needed for closure
Step 4: Closure
- Layered closure with deep absorbable sutures and superficial non-absorbable
- Ensure eversion of wound edges
Panniculitis-Specific Considerations
- Must include subcutaneous fat to depth of at least 1 cm
- Standard punch biopsy is often inadequate
- Incisional or deep excisional biopsy preferred
- Specimen must be oriented and handled carefully to preserve fat lobule architecture
8. Technique: Excisional Biopsy
Definition and Indications
Excisional biopsy removes the entire lesion with a peripheral margin of clinically normal tissue. This is the gold standard for suspected melanoma and provides both diagnostic and therapeutic benefit. [4,5,6,17]
Mandatory Indications
| Indication | Margin | Rationale |
|---|---|---|
| Suspected melanoma | 2mm clinical | Breslow depth determines WLE margin |
| Complete removal of benign lesions | 1-2mm | Therapeutic and cosmetic |
| Lesions where margin status matters | 3-4mm | BCC, SCC margins |
| Atypical naevi | 2mm | Complete removal for diagnosis |
| Dermatofibrosarcoma protuberans | Wide margins | Tumour margins critical |
Margin Guidelines for Initial Excision
| Lesion Type | Recommended Clinical Margin |
|---|---|
| Suspected melanoma (diagnostic) | 2mm |
| Confirmed melanoma (WLE) - Breslow ≤1mm | 1cm |
| Confirmed melanoma - Breslow 1-2mm | 1-2cm |
| Confirmed melanoma - Breslow > 2mm | 2cm |
| BCC (nodular) | 3-4mm |
| BCC (morphoeic/infiltrative) | 5mm+ or Mohs |
| SCC (well-differentiated) | 4-6mm |
| SCC (poorly differentiated) | 6mm+ |
| Benign naevus | 1-2mm or intralesional |
Ellipse Design Principles
The 3:1 Rule:
- Length-to-width ratio of 3:1 prevents "dog ears"
- On tight skin (scalp, shin), 4:1 ratio may be needed
- Smaller ratios cause standing cones at ellipse ends
Orientation:
- Align long axis with RSTLs (Langer's lines)
- On face: follow wrinkle lines
- Scar will contract along wound axis
Calculating Ellipse Dimensions:
- If lesion is 6mm diameter with 2mm margins:
- Width = 6mm + 2mm + 2mm = 10mm
- Length = 10mm × 3 = 30mm (minimum)
Equipment Required
- Sterile marking pen
- Antiseptic solution
- Lidocaine with adrenaline (field block)
- No. 15 scalpel blade (or No. 10 for larger lesions)
- Toothed forceps, scissors, needle holder
- Suture material (deep absorbable + superficial non-absorbable)
- Orientation suture (if required)
- Formalin specimen container
- Skin hooks (optional, for retraction)
Procedure: Step-by-Step
Step 1: Consent and Marking
- Explain scar, infection, bleeding, possibility of wider excision if melanoma
- Mark ellipse with sterile pen including margins
- Photograph lesion if appropriate
Step 2: Anaesthesia
- Perform field block around (not into) the ellipse
- Wait for full effect (vasoconstrictive action of adrenaline)
Step 3: Incision
- Hold scalpel perpendicular to skin surface
- Cut along marked lines in single smooth strokes
- Maintain consistent depth throughout
- Blade angle prevents bevelling (which causes incomplete margins)
Step 4: Excision
- Undermine specimen at level of subcutis
- Use scissors or scalpel for dissection
- Maintain even plane of dissection
- Lift specimen with skin hook or forceps (at edge, not centre)
Step 5: Haemostasis
- Achieve meticulous haemostasis with electrocautery or ties
- Reduce haematoma risk (especially in anticoagulated patients)
Step 6: Specimen Orientation
- Place orientation suture at 12 o'clock position
- Mark on histology form: "Suture at 12 o'clock = superior"
- Essential for margin assessment in melanoma and positive-margin re-excision
Step 7: Closure
| Layer | Suture | Purpose |
|---|---|---|
| Deep dermis | 3-0 or 4-0 absorbable (Vicryl) | Reduce tension, close dead space |
| Superficial | 4-0 to 6-0 non-absorbable (Nylon/Prolene) | Skin edge approximation, eversion |
Key Technical Points:
- Close deep layer first to take tension off wound
- Evert skin edges (slightly raised) - they will flatten
- Avoid tight sutures (cause ischaemia and suture marks)
- Space sutures 3-5mm apart
Step 8: Dressing
- Apply Steri-strips perpendicular to incision
- Cover with non-adherent dressing
- Consider pressure dressing if bleeding risk
Dog Ear Correction
Cause: Ellipse too short (ratio less than 3:1) or tissue redundancy
Correction Technique:
- Identify standing cone at ellipse end
- Undermine around the cone
- Lay skin flat and mark excess as triangle (Burow's triangle)
- Excise triangle
- Close primarily
Prevention: Always design ellipse with adequate length-to-width ratio
Complications
| Complication | Incidence | Prevention | Management |
|---|---|---|---|
| Wound infection | 2-5% | Aseptic technique, prophylaxis for high-risk | Antibiotics, drainage |
| Haematoma | 1-3% | Meticulous haemostasis, pressure dressing | Evacuate if large |
| Wound dehiscence | 1-2% | Layered closure, reduce tension | Secondary intention or re-suture |
| Dog ears | 2-5% | Adequate ellipse ratio | Surgical revision |
| Hypertrophic scar | 2-10% (site dependent) | Avoid tension, follow RSTLs | Silicone, steroid injection |
| Incomplete excision | Variable | Adequate margins, orientation marking | Re-excision |
9. Specimen Handling and Transport
Transport Media Selection
| Transport Medium | Indication | Key Points |
|---|---|---|
| 10% Buffered Formalin | Routine histopathology (H&E) | Standard for most specimens; 10:1 volume ratio |
| Michel's Medium | Direct Immunofluorescence | For autoimmune bullous disease; preserves immunoglobulins |
| Zeus Medium | Extended DIF transport | Alternative to Michel's for longer transport times |
| Fresh/Saline | Tissue culture, genetics | Short transport time; coordinate with lab |
| Sterile Container | Microbiological culture | For suspected infection |
Critical Errors to Avoid
| Error | Consequence | Prevention |
|---|---|---|
| DIF specimen in formalin | Destroys antibodies; DIF fails | Separate pots; clear labelling |
| Inadequate formalin volume | Poor fixation; autolysis | Minimum 10:1 formalin:tissue ratio |
| Crush artefact | Uninterpretable histology | Gentle handling; toothed forceps |
| Wrong patient labelling | Misdiagnosis | Verify at bedside; two identifiers |
| Delayed fixation | Autolysis | Immediate placement in fixative |
| Incomplete clinical information | Pathologist cannot guide diagnosis | Full clinical details on request form |
Histology Request Form Requirements
Every request must include:
- Patient demographics: Full name, DOB, hospital number
- Specimen site: Precise anatomical location
- Clinical description: Size, colour, texture, duration
- Clinical history: Relevant medical history, medications
- Clinical differential diagnosis: Top 2-3 possibilities
- Specific questions: "Is this invasive?" "Are margins clear?"
- Special requests: Immunohistochemistry, DIF, special stains
Sample Documentation
Specimen: 4mm Punch Biopsy Right Upper Arm
Clinical Description: 2cm erythematous scaly plaque, 6-month history
Clinical History: 45F, no significant PMH, family history of psoriasis
Clinical Differential: 1. Psoriasis 2. Eczema 3. Mycosis fungoides
Questions for Pathologist: Inflammatory pattern? Evidence of lymphocyte atypia?
10. Anticoagulation Management
Evidence-Based Approach
Continuing anticoagulation for minor skin surgery is supported by systematic review evidence. The bleeding risk is manageable with appropriate technique, while stopping anticoagulation carries thromboembolic risks. [18,19]
Anticoagulant/Antiplatelet Management
| Agent | Recommendation | Evidence | Notes |
|---|---|---|---|
| Aspirin (monotherapy) | CONTINUE | Level I | Stopping increases cardiovascular events |
| Clopidogrel | CONTINUE | Level I | Same as aspirin for minor surgery |
| DAPT (Aspirin + Clopidogrel) | CONTINUE | Level II | Post-stent patients; never stop both |
| Warfarin | CONTINUE if INR less than 3.5 | Level II | Check INR within 72h; delay if > 3.5 |
| DOACs (Apixaban, Rivaroxaban) | CONTINUE for punch/shave | Level II-III | Consider omitting morning dose for larger excisions |
| Bridging anticoagulation | NOT required | Level I | For minor skin surgery with haemostatic technique |
Haemostasis Strategies for Anticoagulated Patients
- Use adrenaline-containing local anaesthesia (vasoconstriction)
- Meticulous surgical haemostasis (electrocautery for all bleeding points)
- Pressure dressing post-procedure
- Absorbable deep sutures to obliterate dead space
- Elevate limb if lower extremity
- Avoid NSAIDs post-operatively
- Patient education: apply pressure if bleeding occurs
When to Refer for Specialist Input
- INR > 4.0
- Multiple anticoagulants/antiplatelets
- Recent thromboembolic event (less than 3 months)
- Mechanical heart valve
- Large excision (> 2cm) on anticoagulation
- High bleeding risk anatomical sites (scalp, face)
11. Special Situations
Bullous Disease Biopsy Protocol
For suspected autoimmune bullous disease (Bullous Pemphigoid, Pemphigus Vulgaris, Dermatitis Herpetiformis):
Two Biopsies Required:
| Biopsy | Site | Transport Medium | Purpose |
|---|---|---|---|
| Biopsy 1 | Lesional skin (blister edge) | Formalin | H&E histology - shows blister level |
| Biopsy 2 | Perilesional (non-blistered skin, within 1cm of blister) | Michel's/Zeus | Direct Immunofluorescence - shows antibody deposition |
Critical Points:
- DIF MUST be from uninvolved skin adjacent to blister
- Blister fluid destroys immunoglobulins
- Michel's medium (NOT formalin) for DIF specimen
- Label pots clearly to avoid mix-up [11,12]
Vasculitis Biopsy
- Requires deep tissue to visualize blood vessel walls
- Use large punch (4-6mm) or small incisional biopsy
- Sample fresh lesions (less than 48 hours old) - older lesions lose diagnostic features
- Palpable purpura is the target lesion
- Include subcutaneous fat if possible
Melanoma-in-Situ (Lentigo Maligna)
- Edges often ill-defined on sun-damaged skin
- Multiple "scouting punches" may be taken around clinical edge
- Maps the true extent of disease before definitive staged excision
- Staged excision (slow Mohs) or Wood's lamp assessment may be needed
Alopecia Biopsy
| Type | Biopsy Site | Size | Special Requirements |
|---|---|---|---|
| Scarring alopecia | Active edge (erythematous border) | 4mm punch x2 | Horizontal and vertical sections |
| Non-scarring alopecia | Area of maximum activity | 4mm punch x2 | Include terminal and vellus hair |
Technical tip: Two punches allow horizontal sectioning of one (for follicular count) and vertical sectioning of other (for inflammation pattern).
Paediatric Considerations
- Topical anaesthesia (EMLA/LMX) applied 45-60 minutes prior
- Consider intranasal midazolam or oral sedation for anxious children
- Smaller punch sizes (2-3mm) often sufficient
- Absorbable sutures preferred (avoid suture removal)
- Careful site selection for cosmesis
12. Complications and Management
Intraoperative Complications
| Complication | Recognition | Immediate Management |
|---|---|---|
| Excessive bleeding | Obscured operative field | Pressure, identify source, electrocautery, ligature |
| Nerve injury | Visible nerve damage, motor weakness | Avoid further damage, consider repair, document, refer |
| Deep structure injury | Visualization of tendon, vessel | Stop, assess, specialist referral if needed |
| Inadequate anaesthesia | Patient pain | Supplement local anaesthesia |
Post-operative Complications
| Complication | Incidence | Prevention | Management |
|---|---|---|---|
| Wound infection | 2-5% | Aseptic technique, dry wound | Oral antibiotics (flucloxacillin 500mg QDS); drain if abscess |
| Haematoma | 1-3% | Haemostasis, pressure dressing | Small: observe; Large: evacuate |
| Dehiscence | 1-2% | Tension-free closure, appropriate sutures | Secondary intention or re-suture |
| Hypertrophic scar | 2-10% | Follow RSTLs, reduce tension | Silicone gel, intralesional steroid |
| Keloid | 1-5% (predisposed individuals) | Avoid biopsy in keloid-prone sites | Intralesional triamcinolone, silicone |
| Incomplete excision | Variable | Adequate margins, specimen orientation | Re-excision with appropriate margin |
| Suture reaction | less than 5% | Non-reactive suture materials | Remove sutures, antibiotics if infected |
| Contact dermatitis | less than 5% | Hypoallergenic dressings | Remove allergen, topical steroids |
Wound Infection Risk Factors
| Risk Factor | Relative Risk |
|---|---|
| Lower extremity site | 2-3x |
| Diabetes mellitus | 2x |
| Immunosuppression | 3-5x |
| Contaminated wound | 5x |
| Poor nutritional status | 2x |
| Smoking | 2x |
13. Post-Procedure Care
Patient Instructions
First 24-48 Hours:
- Keep dressing clean and dry
- Take paracetamol for discomfort (avoid NSAIDs - increase bleeding)
- Elevate site if on limb
- Avoid strenuous activity
After 48 Hours:
- May shower gently; pat dry
- Keep wound covered until sutures removed
- Avoid swimming, baths, saunas until healed
Suture Removal Timing:
| Anatomical Site | Suture Removal | Full Healing |
|---|---|---|
| Face | 5-7 days | 2-4 weeks |
| Scalp | 7-10 days | 4-6 weeks |
| Trunk/Upper limb | 10-14 days | 6-8 weeks |
| Lower limb/Foot | 14-21 days | 8-12 weeks |
Warning Signs (Seek Medical Attention):
- Increasing redness, warmth, or swelling around wound
- Purulent discharge or pus
- Fever
- Bleeding that doesn't stop with 10 minutes of firm pressure
- Wound opening (dehiscence)
Written Aftercare Information
Provide written instructions including:
- Wound care instructions
- Expected healing timeline
- Activity restrictions
- Warning signs
- Contact information for concerns
- Follow-up appointment details
14. Histology Interpretation
Understanding the Dermatopathology Report
| Term | Meaning | Clinical Significance |
|---|---|---|
| Breslow depth (mm) | Vertical thickness from granular layer to deepest melanoma cell | less than 1 |
| mm: Good prognosis; > 4 | ||
| mm: Poor prognosis; Determines WLE margin | ||
| Clark level | Anatomical depth (I-V: epidermis to subcutis) | Largely replaced by Breslow; may be used when Breslow less than 1mm |
| Mitotic rate | Mitoses per mm² | High rate indicates aggressive behaviour |
| Ulceration | Absence of epidermis over tumour | Upstages melanoma; worse prognosis |
| Regression | Host immune response destroying tumour | May indicate true depth was greater |
| Microsatellites | Tumour deposits > 0.05mm from main tumour | Indicates aggressive disease; upstages |
| Perineural invasion | Tumour around nerves | Risk of recurrence; may need wider margin |
| Lymphovascular invasion | Tumour in vessels | Risk of metastasis |
Common Histological Patterns
| Pattern | Characteristic | Associated Conditions |
|---|---|---|
| Spongiotic | Intercellular oedema in epidermis | Eczema, contact dermatitis |
| Psoriasiform | Regular elongation of rete ridges, parakeratosis | Psoriasis, pityriasis rubra pilaris |
| Interface | Basal layer damage at dermal-epidermal junction | Lichen planus, lupus, drug eruption |
| Lichenoid | Band-like lymphocytic infiltrate at DEJ | Lichen planus, lichenoid drug eruption |
| Vasculitic | Vessel wall inflammation, fibrinoid necrosis | Leukocytoclastic vasculitis, HSP |
| Granulomatous | Granuloma formation (epithelioid histiocytes) | Sarcoidosis, granuloma annulare, TB |
| Subepidermal blister | Blister below epidermis | Bullous pemphigoid, epidermolysis bullosa |
| Intraepidermal blister | Blister within epidermis | Pemphigus vulgaris, pemphigus foliaceus |
Direct Immunofluorescence Patterns
| Pattern | Antibody Location | Diagnosis |
|---|---|---|
| Linear IgG/C3 at BMZ | Basement membrane zone | Bullous pemphigoid |
| Chicken-wire IgG | Intercellular spaces | Pemphigus vulgaris |
| Granular IgA at dermal papillae | Tips of papillae | Dermatitis herpetiformis |
| Linear IgA at BMZ | Basement membrane | Linear IgA disease |
| Granular at BMZ | Basement membrane | Lupus band test positive |
15. Common Pitfalls and Medicolegal Issues
Critical Errors
| Error | Clinical Consequence | Medicolegal Risk | Prevention |
|---|---|---|---|
| Shaving a melanoma | Breslow depth lost; staging impossible | High - delayed diagnosis, understaging | Excise all suspicious pigmented lesions |
| Wrong transport medium | DIF fails; diagnosis delayed | Moderate | Clear labelling; two pots pre-prepared |
| Crush artefact | Histology uninterpretable | Moderate | Gentle handling; proper forceps technique |
| Inadequate clinical history | Pathologist unable to guide diagnosis | Moderate | Complete request forms |
| Wrong site biopsy | Diagnosis of wrong lesion | High | Mark before procedure; verify with patient |
| Failure to follow-up results | Delayed diagnosis and treatment | Very high | Robust recall system |
| Inadequate consent | Patient unaware of implications | Moderate | Document discussion fully |
Documentation Standards
Every procedure note should include:
- Indication: Why biopsy performed
- Consent: Documented discussion of risks and alternatives
- Site: Precise anatomical location
- Technique: Type of biopsy, punch size, or excision dimensions
- Anaesthetic: Type, volume, with/without adrenaline
- Findings: Macroscopic appearance of lesion
- Specimen: Where sent, which medium
- Closure: Suture type and number
- Complications: Any intraoperative issues
- Follow-up: Plan for review and results
Sample Procedure Note
PROCEDURE NOTE
Date: [Date]
Procedure: 4mm Punch Biopsy Left Shin
Indication: 6-month history of persistent scaly erythematous plaque, ? psoriasis vs. eczema
Consent: Verbal consent obtained. Risks (bleeding, infection, scar) discussed. Patient understands.
Anaesthetic: 1mL Lidocaine 2% with Adrenaline 1:100,000 infiltrated locally.
Procedure: Site prepped with chlorhexidine. 4mm punch biopsy performed using one-directional
technique. Core removed intact with toothed forceps at base (no crush).
Haemostasis achieved with pressure.
Closure: Single 4-0 Nylon simple interrupted suture.
Specimen: Sent in 10% buffered formalin to Dermatopathology.
Complications: None.
Post-op: Wound care advice given. Review with histology in 2 weeks. Suture removal in 14 days.
Signed: Dr [Name], [Date]
16. Examination Scenarios
Viva Scenario 1: Pigmented Lesion
Stem: 45-year-old woman with a 6mm irregularly pigmented lesion on her back. Dermoscopy shows irregular network and blue-white veil. What biopsy?
Model Answer:
"This lesion has dermoscopic features concerning for melanoma, specifically the irregular network and blue-white veil. The appropriate biopsy technique is complete excision with a 2mm clinical margin.
Shave biopsy is absolutely contraindicated as it would prevent accurate Breslow depth measurement, which is essential for staging and determining the subsequent wide local excision margin.
I would orient the specimen with a suture at 12 o'clock to allow the pathologist to identify margins for potential re-excision. If melanoma is confirmed, the Breslow depth will determine the WLE margin: 1cm for ≤1mm, 1-2cm for 1-2mm, and 2cm for > 2mm."
Viva Scenario 2: Inflammatory Rash
Stem: 70-year-old man with a persistent scaly red plaque on face, present for 2 years. Clinical differential is Bowen's disease vs. SCC vs. psoriasis. What biopsy?
Model Answer:
"For this well-defined plaque with differential diagnosis including neoplastic (Bowen's, SCC) and inflammatory (psoriasis) conditions, I would perform a 4mm punch biopsy.
This provides full-thickness tissue allowing assessment of:
- Depth of invasion (if SCC)
- Presence of in-situ vs. invasive disease
- Inflammatory pattern (if psoriasis)
I would take the biopsy from the active edge of the lesion, avoiding any central ulceration. If histology confirms invasive SCC, definitive excision with 4-6mm margins would follow."
Viva Scenario 3: Bullous Disease
Stem: 65-year-old presents with tense blisters on limbs and trunk. You suspect Bullous Pemphigoid. How many biopsies and from where?
Model Answer:
"For suspected Bullous Pemphigoid, I would take two separate biopsies:
Lesional biopsy: 4mm punch from the edge of a fresh blister, placed in formalin for H&E. This will show subepidermal blister with eosinophils.
Perilesional biopsy: 4mm punch from uninvolved skin within 1cm of a blister (not blistered skin), placed in Michel's transport medium for Direct Immunofluorescence. This will show linear IgG and C3 at the basement membrane zone.
It is critical that the DIF specimen comes from perilesional non-blistered skin, as blister fluid destroys immunoglobulins. Formalin must NOT be used for DIF specimens."
Viva Scenario 4: Anticoagulated Patient
Stem: Patient on Warfarin (INR 2.8) needs a punch biopsy for a rash. What do you do?
Model Answer:
"I would proceed with the biopsy. An INR of 2.8 is within acceptable range (less than 3.5) for minor skin surgery.
My haemostatic strategy would include:
- Using lidocaine with adrenaline for vasoconstriction
- Electrocautery or aluminium chloride for haemostasis
- Pressure dressing post-procedure
- Suture closure rather than secondary intention
Current evidence supports continuing anticoagulation for minor skin procedures as the thromboembolic risk of stopping anticoagulation outweighs the manageable bleeding risk with appropriate technique."
Viva Scenario 5: Crush Artefact
Stem: FY2 doctor takes a punch biopsy but the pathology report says "Crush artefact. Uninterpretable."
Model Answer:
"Crush artefact occurs when the specimen is damaged during removal, typically by squeezing the diagnostic tissue with forceps.
The correct technique is:
- Use toothed forceps (not smooth)
- Grasp the specimen at the deep edge (subcutaneous fat), not the diagnostic dermis
- Handle with minimal compression
- Use one-directional twisting of the punch to avoid shredding collagen
The biopsy would need to be repeated using proper technique. This represents a preventable error that delays diagnosis and subjects the patient to an additional procedure."
17. Training Competency Framework
Expected Skill Progression
| Skill | Medical Student | FY1 | FY2 | ST3+ (Specialty) |
|---|---|---|---|---|
| Local anaesthesia | Observed | Supervised | Independent | Independent |
| Simple suturing | Assisted | Supervised | Independent | Independent |
| Shave biopsy | Observed | Supervised | Independent | Independent |
| Punch biopsy | Observed | Observed/Assisted | Supervised/Independent | Independent |
| Ellipse excision | Observed | Observed | Assisted/Supervised | Independent |
| Complex excision | Not expected | Not expected | Observed | Supervised/Independent |
Assessment Criteria
Competence should be assessed against:
- Knowledge: Indications, contraindications, anatomy, complications
- Technical skill: Smooth technique, tissue handling, closure quality
- Decision-making: Appropriate technique selection for lesion type
- Communication: Consent, explanation, post-procedure instructions
- Documentation: Complete and accurate procedure notes
- Professionalism: Preparation, aseptic technique, equipment familiarity
18. Patient/Layperson Explanation
What is a Skin Biopsy?
A skin biopsy is a simple procedure where a small sample of your skin is taken and examined under a microscope. This helps doctors find out what is causing a rash, lump, or skin change.
Types of Skin Biopsy
- Shave biopsy: A thin layer is shaved from the surface (like shaving off a raised mole)
- Punch biopsy: A small circular sample is taken (like using a tiny cookie cutter)
- Excision biopsy: The entire lump is removed with a small border of normal skin
Does it Hurt?
You will receive an injection of local anaesthetic (the same kind dentists use). The injection stings briefly, but after that the area is numb and you should feel no pain during the procedure.
Will it Leave a Scar?
There will be a small scar. The size depends on the type of biopsy. Most scars heal very well and fade significantly over several months. Your doctor will position the cut to minimize scarring.
How Long Does it Take?
The procedure takes about 5-15 minutes. You can go home immediately afterwards.
Aftercare
- Keep the wound clean and dry for 48 hours
- Take paracetamol if needed for discomfort
- Follow the wound care instructions provided
- Attend for suture removal if needed (usually 5-14 days depending on location)
- Watch for signs of infection: increasing redness, swelling, pus, or fever
When Will I Get Results?
Usually 1-2 weeks. Your GP or specialist will contact you with the results and discuss any further treatment needed.
19. Evidence and Guidelines
Key Guidelines
| Guideline | Organisation | Year | Key Recommendations |
|---|---|---|---|
| Skin Biopsy Techniques | BAD (British Association of Dermatologists) | 2021 | Best practice for technique selection, specimen handling |
| Melanoma Management | NICE NG14 | 2015 (Updated 2022) | 2mm clinical margin for diagnostic excision; WLE margins by Breslow |
| Skin Cancer Management | Cancer Council Australia | 2020 | Excisional biopsy mandatory for suspected melanoma |
| NCCN Melanoma Guidelines | NCCN | 2024 | Narrow margin excision for diagnosis; appropriate margins for treatment |
| Perioperative Anticoagulation | ACCP | 2012 | Continue anticoagulation for minor dermatologic procedures |
Evidence Summary
| Intervention | Evidence Level | Key Finding |
|---|---|---|
| Excision for suspected melanoma | Level I | Mandatory for accurate Breslow staging; shave biopsy contraindicated |
| Punch biopsy for inflammatory dermatoses | Level II | Full dermis required for histological pattern recognition |
| Adrenaline in digital blocks | Level I | Safe; no digital necrosis in > 10,000 reported cases |
| Continuing anticoagulation | Level I | Safe for minor skin surgery with appropriate haemostatic technique |
| Michel's medium for DIF | Level II | Superior preservation of immunoreactants vs. formalin |
| 3:1 ellipse ratio | Level III | Prevents dog-ear deformity |
20. References
-
Nischal U, Nischal Kc, Khopkar U. Techniques of skin biopsy and practical considerations. J Cutan Aesthet Surg. 2008;1(2):107-111. doi:10.4103/0974-2077.44174
-
Alguire PC, Mathes BM. Skin biopsy techniques for the internist. J Gen Intern Med. 1998;13(1):46-54. doi:10.1046/j.1525-1497.1998.00009.x
-
Pickett H. Shave and punch biopsy for skin lesions. Am Fam Physician. 2011;84(9):995-1002. PMID: 22046940
-
Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Arch Dermatol. 2010;146(3):234-239. doi:10.1001/archdermatol.2010.14
-
Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208-250. doi:10.1016/j.jaad.2018.08.055
-
Saco M, Thigpen J. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management. J Drugs Dermatol. 2014;13(5):531-536. PMID: 24809875
-
Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720. doi:10.1016/S1470-2045(08)70178-5
-
Lalonde D, Bell M, Benoit P, Sparkes G, Denkler K, Chang P. A multicenter prospective study of 3,110 consecutive cases of elective epinephrine use in the fingers and hand: the Dalhousie Project clinical phase. J Hand Surg Am. 2005;30(5):1061-1067. doi:10.1016/j.jhsa.2005.05.006
-
Thomson CJ, Lalonde DH, Denkler KA, Feicht AJ. A critical look at the evidence for and against elective epinephrine use in the finger. Plast Reconstr Surg. 2007;119(1):260-266. doi:10.1097/01.prs.0000237039.71227.11
-
Ilicki J. Safety of epinephrine in digital nerve blocks: a literature review. J Emerg Med. 2015;49(5):799-809. doi:10.1016/j.jemermed.2015.06.025
-
Mutasim DF, Adams BB. Immunofluorescence in dermatology. J Am Acad Dermatol. 2001;45(6):803-824. doi:10.1067/mjd.2001.117518
-
Vodegel RM, Jonkman MF, Pas HH, de Jong MC. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol. 2004;151(1):112-118. doi:10.1111/j.1365-2133.2004.06006.x
-
Linos E, Katz KA, Colditz GA. Skin cancer—the importance of prevention. JAMA Intern Med. 2016;176(10):1435-1436. doi:10.1001/jamainternmed.2016.5008
-
Borges AF. Relaxed skin tension lines (RSTL) versus other skin lines. Plast Reconstr Surg. 1984;73(1):144-150. doi:10.1097/00006534-198401000-00036
-
Elston DM, Stratman EJ, Miller SJ. Skin biopsy: Biopsy issues in specific diseases. J Am Acad Dermatol. 2016;74(1):1-16. doi:10.1016/j.jaad.2015.06.033
-
Scolyer RA, Thompson JF, McCarthy SW, et al. Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis. Australas J Dermatol. 2006;47(1):71-75. doi:10.1111/j.1440-0960.2006.00230.x
-
Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599-609. doi:10.1056/NEJMoa1310460
-
Shimizu I, Jellinek NJ, Engel S, Engel ER. Anticoagulant and antiplatelet agent use in dermatologic surgery. Dermatol Surg. 2019;45(10):1226-1244. doi:10.1097/DSS.0000000000001837
-
Lewis KG, Dufresne RG Jr. A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg. 2008;34(2):160-165. doi:10.1111/j.1524-4725.2007.34035.x
-
Bordeaux JS, Martires KJ, Goldberg D, Pattee SF, Fu P, Maloney ME. Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications. J Am Acad Dermatol. 2011;65(3):576-583. doi:10.1016/j.jaad.2011.02.012
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. This does not replace supervised training for procedures.
Evidence trail
This article contains inline citation markers, but the full bibliography has not yet been imported as a visible references section. The page is still tracked through the editorial review pipeline below.
All clinical claims sourced from PubMed
Learning map
Use these linked topics to study the concept in sequence and compare related presentations.
Prerequisites
Start here if you need the foundation before this topic.
- Skin Anatomy
- Local Anaesthesia Pharmacology
Differentials
Competing diagnoses and look-alikes to compare.
- Melanoma Staging
- Inflammatory Dermatoses
Consequences
Complications and downstream problems to keep in mind.
- Wound Healing
- Scar Management